SEC Form 4 · accession 0001179110-17-000514
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maxine Gowen
Director
Period of report
Jan 4, 2017
Accepted (ET)
Jan 5, 2017 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2017 | A | 7,000 | $1.50 | A | 17,543 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This stock was issued to the reporting person pursuant to her election under the Issuer's director compensation program in lieu of cash.